+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID06698146

Study Comparing Different Approved Liver Transplant Methods for Patients with Colorectal Cancer Liver Metastases

Led by Northwestern University · Updated on 2026-07-10

80

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating different approved liver transplant methods for patients with colorectal cancer that has spread to the liver and cannot be removed by surgery. The study compares living donor versus deceased donor transplants, whole organ versus split liver transplants, and one-stage versus two-stage transplant procedures. The goal is to understand the clinical outcomes, hospital recovery, and one-year survival rates after liver transplantation for these patients. Participants may undergo one of several transplant procedures, including living donor liver transplant using right or left lobe grafts, two-stage procedures involving partial liver grafts with delayed total liver removal, or whole liver transplants from deceased donors allocated based on the MELD scoring system. The two-stage procedures involve an initial transplant using a partial donor liver followed by removal of the native liver after the transplanted liver has grown sufficiently. During the study, participants clinical progress after liver transplant is monitored, including survival and recovery outcomes over 12 months. Blood samples are also collected for future research. Researchers focus on graft and patient survival outcomes from transplant up to one year. Participation involves tracking recovery in the hospital and follow-up evaluations to measure transplant success and patient health over time.

CONDITIONS

Brief Title

Colorectal Metastasis to Liver Extraction With Auxiliary Transplant and Delayed Resection

Research Team

Y

Yajaira Navarro

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here